Daniel Furst, MD
Carl M. Pearson Chair of Rheumatology
UNIVERSITY OF CALIFORNIA LOS ANGELES
UNIVERSITY OF CALIFORNIA LOS ANGELES
Member of the Healthcare Council
Daniel Furst, MD, is the Carl M. Pearson Chair of Rheumatology and Director of Interventional Therapeutics at University of California, Los Angeles Medical Center for Health Sciences. Dr. Furst has expertise in clinical pharmacology of anti-rheumatic drugs, scleroderma, and rheumatoid arthritis. (This is me - Update Profile)
| 2002 - present | Carl M. Pearson Chair of Rheumatology UNIVERSITY OF CALIFORNIA LOS ANGELES |
|---|
GLG Study Groups with Daniel Furst, MD(?)
| Study Group Name | Members |
|---|---|
| Rheumatologists | 860 |
| Rituxan Prescribers: Rheumatologists | 35 |
GLG NewsSM Analyses by Daniel Furst, MD(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Daniel Furst, MD has not published any public GLG News analyses.
View all GLG News in Healthcare
View all GLG News in Healthcare
GLG InstituteSM Seminars with Daniel Furst, MD(?)
Daniel Furst, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare
View all GLG InstituteSM Seminars in Healthcare
Request a project with Daniel Furst, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 850+ Clients Include:
Fortune 500®
companies
40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
global private equity firms
5 of the top 10
AmLaw firms